Publications by authors named "Peggy Manders"

27Publications

A Stepwise Procedure to Define a Data Collection Framework for a Clinical Biobank.

Biopreserv Biobank 2018 Apr 13;16(2):138-147. Epub 2018 Feb 13.

1 Radboud Biobank, Radboud University Medical Center , Nijmegen, the Netherlands .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/bio.2017.0084DOI Listing
April 2018

Patients to learn from: on the need for systematic integration of research and care in academic health care.

J Clin Transl Res 2018 Dec 14;3(Suppl 3):401-406. Epub 2017 Sep 14.

Radboud Biobank, Radboud university medical center, Nijmegen, the Netherlands.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412601PMC
December 2018

International biobanks: do or do not?

Future Sci OA 2015 Nov 22;1(4):FSO75. Epub 2015 Sep 22.

Radboud Biobank, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Biobank, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/fso.15.75DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138003PMC
November 2015

Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.

Gastroenterology 2015 Oct 11;149(4):897-906.e19. Epub 2015 Jun 11.

Department of Pathology, Radboud university medical center, Nijmegen, The Netherlands; Department of Human Genetics, Radboud university medical center, Nijmegen, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.06.003DOI Listing
October 2015

Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers.

J Clin Epidemiol 2011 Dec 20;64(12):1434-43. Epub 2011 Jul 20.

Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2011.04.005DOI Listing
December 2011

Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers.

Eur J Epidemiol 2010 Feb;25(2):103-13

Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10654-009-9416-x
Publisher Site
http://dx.doi.org/10.1007/s10654-009-9416-xDOI Listing
February 2010

Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers.

Breast Cancer Res Treat 2010 Feb 13;120(1):235-44. Epub 2009 Aug 13.

Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-009-0476-0DOI Listing
February 2010

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Am J Hum Genet 2008 Apr 20;82(4):937-48. Epub 2008 Mar 20.

Cancer Research UK, Genetic Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajhg.2008.02.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427217PMC
April 2008

High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer.

Breast Cancer Res Treat 2006 Jul 16;98(2):223-30. Epub 2006 Mar 16.

Department of Chemical Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-005-9153-0DOI Listing
July 2006

Survivin is an independent prognostic marker for risk stratification of breast cancer patients.

Clin Chem 2004 Nov 13;50(11):1986-93. Epub 2004 Sep 13.

Departments of Chemical Endocrinology, Clinical Chemistry, Medical Oncology, University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2004.039149DOI Listing
November 2004

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.

J Pathol 2004 Apr;202(4):395-402

Department of Chemical Endocrinology, University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1528DOI Listing
April 2004

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma.

Cancer 2003 Nov;98(10):2125-32

Department of Chemical Endocrinology, University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.11764DOI Listing
November 2003

Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer.

Oncogene 2003 Jul;22(31):4898-904

Department of Chemical Endocrinology, University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206818DOI Listing
July 2003

Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-beta-3, -5, and -8 mRNAs has prognostic value in breast cancer.

Clin Chem 2003 Jul;49(7):1074-80

Department of Chemical Endocrinology, University Medical Center Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/49.7.1074DOI Listing
July 2003

E1AF expression levels are not associated with prognosis in human breast cancer.

Breast Cancer Res Treat 2003 May;79(1):129-31

Department of Chemical Endocrinology, University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1023/a:1023338424677DOI Listing
May 2003

Expression of the transcription factor Ets-1 is an independent prognostic marker for relapse-free survival in breast cancer.

Oncogene 2002 Dec;21(55):8506-9

Department of Chemical Endocrinology, University Medical Center Nijmegen, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206040DOI Listing
December 2002